The Nitric oxide/CGMP/KATP pathway mediates systemic and central antinociception induced by resistance exercise in rats

International Journal of Neuroscience

Volumn 125, Issue 10, 2015, Pages 765-773

  Galdino, Giovane S ^a   Xavier, Carlos H ^a   Almeida, Renato ^a   Silva, Grazielle ^a   Fontes, Marcos A ^a   Menezes, Gustavo ^a   Duarte, Igor D ^a   Perez, Andrea C ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antinociception; Nitric oxide; Resistance exercise

Indexed keywords

1H [1,2,4]OXIDIAZOLO[4,3 A]QUINOXALIN 1 ONE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AMINOGUANIDINE; CYCLIC GMP; GLIBENCLAMIDE; GUANYLATE CYCLASE INHIBITOR; N(G) NITROARGININE; N(G) PROPYLARGININE; N5 (1 IMINOETHYL)ORNITHINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; UNCLASSIFIED DRUG; 1H-(1,2,4)OXADIAZOLO(4,3-A)QUINOXALIN-1-ONE; ARGININE; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; GUANYLATE CYCLASE; N(G)-IMINOETHYLORNITHINE; ORNITHINE; OXADIAZOLE DERIVATIVE; QUINOXALINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTROLLED STUDY; MALE; MEASUREMENT ACCURACY; NEUROTRANSMISSION; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; RAT; RESISTANCE TRAINING; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; WEIGHT LIFTING; WISTAR RAT; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DRUG EFFECTS; METABOLISM; NOCICEPTION; PAIN MEASUREMENT; PHYSIOLOGY;

ANIMALS; ARGININE; CYCLIC GMP; ENZYME INHIBITORS; GLYBURIDE; GUANIDINES; GUANYLATE CYCLASE; KATP CHANNELS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITES; NITROARGININE; NOCICEPTION; ORNITHINE; OXADIAZOLES; PAIN MEASUREMENT; PHYSICAL CONDITIONING, ANIMAL; QUINOXALINES; RATS; SIGNAL TRANSDUCTION;

EID: 84924773367     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2014.970256     Document Type: Article

References (55)

1. Atha J. Strengthening muscle. Exerc Sport Sci Rev 1981; 9: 1-73.
2. Sale D. 2nd ed. Vol. 3, Strength and power in sport. Blackwell Science (UK): P.V. Komi; C2003. Chapter 15, Neural adaptation to strength training; pp. 281-314.
3. Pollock M, Franklin B, Balady G, et al. AHA science advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: an advisory from the committee on exercise, rehabilitation, and prevention, council on clinical cardiology, American Heart Association; position paper endorsed by the American College of Sports Medicine. Circulation 2000; 101: 828-833.
4. Koltyn K, Argobast, R. Perception of pain after resistance exercise. Br J Sports Med 1998; 32: 20-24.
5. Ayan C, Alvarez M, Alonso-Cortés B, et al. Health education home-based program in females with fibromyalgia: A pilot study. J Back Musculoskelet Rehabil 2009; 22: 99-105.
6. Hurkmans E, Van Der Giesen F, Vliet Vlieland T, et al. Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev 2009; 4: cd006853.
7. Jackson J, Shepherd T, Kell R. The influence of periodized resistance training on recreationally active males with chronic nonspecific low back pain. J Strength Cond Res 2011; 25: 224-251.
8. Galdino G, Duarte I, Perez A. Participation of endogenous opioids in the antinociception induced by resistance exercise in rats. Braz J Med Biol Res 2010; 43: 906-909.
9. de Souza G, Duarte I, de Castro Perez A. Differential involvement of central and peripheral 2 adrenoreceptors in the antinociception induced by aerobic and resistance exercise. Anesth Analg 2013; 116: 703-711.
10. Esplugues J. NO as a signaling molecule in the nervous system. Br J Pharmacol 2002; 135: 1079-1095.
11. Nathan C. Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100: 2417-2423.
12. Osborne M, Coderre T. Effects of intrathecal administration of nitric oxide synthase inhibitors on carrageenan-induced thermal hyperalgesia. Br J Pharmacol 1999; 126: 1840-1846.
13. Reid M. Role of nitric oxide in skeletal muscle: synthesis, distribution and functional importance. Acta Physiol Scand 1998; 162: 401-409.
14. Galdino G, Cortes S, Duarte I, Perez A. Involvement of the Nitric Oxide/cGMP/KATP pathway in antinociception induced by exercise in rats. Life Sci 2010; 86: 505-509.
15. Hara S, Kuhns E, Ellenberger E, et al. Involvement of nitric oxide in intracerebroventricular β-endorphin-induced neuronal release of methionine-enkephalin. Brain Res 1995; 675: 190-194.
16. Germany A, González P, Contreras E. Possible role of nitric oxide in the antinociceptive action of intraventricular bradykinin in mice. Eur J Pharmacol 1996; 310: 123-127.
17. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110.
18. Mestre C, Pelissier T, Fialip J, et al. A method to perform direct transcutaneous intrathecal injection in rat. J Pharmacol Toxicol Methods 1994; 32: 197-200.
19. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Toronto: Academic Press; 2006: 456. pp.
20. Tamaki T, Uchiyama S, Nakano A. Weight-lifting exercise model for inducing hypertrophy in the hindlimb muscles of rats. Med Sci Sports Exerc 1992; 24: 881-886.
21. Randall L, Sellito J. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 1957; 111: 409-419.
22. Nirogi R, Kandikere V, Mudigonda K, et al. A simple and rapid method to collect the cerebrospinal fluid of rats and its application for the assessment of drug penetration into the central nervous system. J Neurosci Methods 2009; 178: 116-119.
23. Green L, Wagner D, Glogowski J, et al. Analysis of nitrate, nitrite and [15n]nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
24. Anshel M, Russel K. Effect of aerobic and strength training on pain tolerance, pain appraisal and mood of unfit males as a function of pain location. J Sports Sci 1994; 12: 535-547.
25. Bartholomew J, Lewis B, Linder D. Post-exercise analgesia: replication and extension. J Sports Sci 1996; 14: 29-334.
26. Kraemer W, Fry A, Warren B, Stone M, Fleck S, Kearney J, et al. Acute hormonal responses in elite junior weightlifters. Int J Sports Med 1992; 13: 103-109.
27. Walberg-Rankin J, Franke W, Gwazdauskas F. Response of beta-endorphin and estradiol to resistance exercise in females during energy balance and energy restriction. Int J Sports Med 1992; 13: 542-547.
28. Kraemer W, Dziados J, Marchitelli L, et al. Effects of different heavy-resistance exercise protocols on plasma β-endorphin concentrations. J Appl Physiol 1993; 74: 450-459.
29. Duarte I, Nakamura M, Ferreira S. Peripheral analgesia and activation of the nitric oxide cyclic GMP pathway. Eur J Pharmacol 1990; 186: 289-293.
30. Xu J, Pieper G, Tseng L. Activation of a no-cyclic GMP system by no donors potentiates beta-endorphin-induced antinociception in the mouse. Pain 1995; 6: 377-383.
31. Pacheco D, Reis G, Francischi J, et al. δ-opioid receptor agonist snc80 elicits peripheral antinociception via δ1 and δ2 receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway. Life Sci 2005; 78: 54-60.
32. Guzel N, Hazar S, Herbas D. Effects of different resistance exercise protocols on nitric oxide, lipid peroxidation and creatine kinase activity in sedentary males. J Sports Sci Med 2007; 6: 417-422.
33. Cunha T, Roman-Campos D, Lotufo C, et al. Morphine peripheral analgesia depends on activation of the p13kgamma/ATP/nNOS/NO/KATP signaling pathway. Proc Natl Acad Sci USA 2010; 107: 4442-4447.
34. Kingwell B. Nitric oxide-mediated metabolic regulation during exercise: effects of training in health and cardiovascular disease. Faseb J 2000; 14: 1685-1696.
35. Mcconell G, Bradley S, Stephens T, et al. Skeletal muscle nnos mu protein content is increased by exercise training in humans. Am J Physiol Regul Integr Comp Physiol 2007; 293: 821-828.
36. Tschakovsky M, Joyner M. Nitric oxide and muscle blood flow in exercise. Appl Physiol Nutr Met 2008; 33: 151-161.
37. Chavoshan B, Fournier M, Lewis M, et al. Testosterone and resistance training effects on muscle nitric oxide synthase isoforms in COPD men. Respir Med 2011; 106: 269-275.
38. Chalimoniuk M, Wronski Z, Gilewski K, et al. Does exercise training affect NO/GC/cGMP pathway in the brain?. J Hum Kinet 2005; 13: 27-40.
39. Young M, Radda G, Leighton B. Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem J 1997; 322: 223-328.
40. Young M, Leighton B. Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle. Biochem J 1998; 329: 73-79.
41. Deshmukh A, Long Y, de Castro Barbosa T, et al. Nitric oxide increases cyclic GMP levels, amp-activated protein kinase (AMPk)1-specific activity and glucose transport in human skeletal muscle. Diabetologia 2010; 53: 1142-1150.
42. Garthwaite G, Bartus K, Malcolm D, et al. Signaling from blood vessels to CNS axons through nitric oxide. J Neurosc 2006; 26: 7730-7740.
43. Baukrowitz T, Fakle B. KATP channels gated by intracellular nucleotides and phospholipids. Eur J Biochem 2000; 267: 5842-5848.
44. Brown D, Lynch J, Armstrong C, et al. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sexdependent in the rat. J Physiol 2005; 564: 619-630.
45. Bloomer R, Smith W, Fisher-Wellman K. Glycine propionyl-l-carnitine increases plasma nitrate/nitrite in resistance trained men. J Int Soc Sports Nutr 2007; 4: 22-27.
46. Zhang Y, Lee T, Kolb E, et al. AMP-activated protein kinase is involved in endothelial no synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 2006; 26: 1281-1287.
47. Gladwin M, Schechter A, Kim-Shapiro D, et al. The emerging biology of the nitrite anion. Nat. Chem. Biol. 2005; 1: 308-314.
48. Conahey G, Power G, Hopper A, et al. 2008. Blood A: effect of inhaled nitric oxide on cerebrospinal fluid and blood nitrite concentrations in newborn lambs. Pediatr Res 64: 375-380.
49. Cannon J, Prieto G, Lee A, Liebeskind J. Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat. Brain Res 1982; 243: 315-321.
50. Millan M. Descending control of pain. Progr Neurobiol 2002; 66: 355-474.
51. de Luca M, Brandao M, Motta V, Landeira-Fernandez J. Antinociception induced by stimulation of ventrolateral periaqueductal gray at the freezing threshold is regulated by opioid and 5-HT2a receptors as assessed by the tail-flick and formalin tests. Pharmacol Biochem Behav 2003; 75: 459-466.
52. Lovick T. Role of nitric oxide in medullary raphe-evoked inhibition of neuronal activity in the periaqueductal gray matter. Neuroscience 1996; 75: 1203-1209.
53. Ishide T, Amer A, Maher T, Ally A. Nitric oxide within periaqueductal gray modulates glutamatergic neurotransmission and cardiovascular responses during mechanical and thermal stimuli. Neuroscience Res 2005; 51: 93-103.
54. Chaitoff K, Patel D, Ally A. Effects of endothelial nos antagonism within the periaqueductal gray on cardiovascular responses and neurotransmission during mechanical, heat, and cold nociception. Brain Res 2008; 1236: 93-104.
55. Hämäläinen M, Lovick T. Involvement of nitric oxide and serotonin in modulation of antinociception and pressor responses evoked by stimulation in the dorsolateral region of the periaqueductal gray matter in the rat. Neuroscience 1997; 80: 821-827.